Cas:887351-41-9 N-Cyclopropyl-2-nitro-4-(trifluoromethyl)aniline manufacturer & supplier

We serve Chemical Name:N-Cyclopropyl-2-nitro-4-(trifluoromethyl)aniline CAS:887351-41-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-Cyclopropyl-2-nitro-4-(trifluoromethyl)aniline

Chemical Name:N-Cyclopropyl-2-nitro-4-(trifluoromethyl)aniline
CAS.NO:887351-41-9
Synonyms:n-cyclopropyl-2-nitro-4-trifluoromethylaniline
Molecular Formula:C10H9F3N2O2
Molecular Weight:246.18600
HS Code:2921420090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:57.85000
Exact Mass:246.06200
LogP:3.78410

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like n-cyclopropyl-2-nitro-4-trifluoromethylaniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,n-cyclopropyl-2-nitro-4-trifluoromethylaniline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,n-cyclopropyl-2-nitro-4-trifluoromethylaniline Use and application,n-cyclopropyl-2-nitro-4-trifluoromethylaniline technical grade,usp/ep/jp grade.


Related News: As Natural Capsules did not have access to this manufacturing technology, its R&D centre, which is DSIR approved, had started working on the same since 2018, and has now successfully developed the process including fermentation and chemical synthesis steps, Sunil Mundra, managing director, Natural Capsules told Pharmabiz. 4-[4-(3-cyclopentyloxy-4-methoxyphenyl)-2-oxopyrrolidin-1-yl]benzenesulfonamide manufacturers This project is supported by the Irish Government through IDA Ireland. 3-nitroquinoline-4-carboxaldehyde suppliers IDA Ireland Executive Director Mary Buckley said: “Charles River is an employer of long-standing in Co. Mayo. The enhancement of its product lines and the development of additional capability at the Ballina facility is most welcome. 4-O-ethyl 3-O-methyl 1-(4-chlorophenyl)-5-phenylpyrazole-3,4-dicarboxylate vendor & factory After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece.,As Natural Capsules did not have access to this manufacturing technology, its R&D centre, which is DSIR approved, had started working on the same since 2018, and has now successfully developed the process including fermentation and chemical synthesis steps, Sunil Mundra, managing director, Natural Capsules told Pharmabiz.